top of page
Our Publications
A New Paradigm for Classifying and Treating HER2-Positive Breast Cancer
Xuexin He, MD, Sai-Ching Yeung, MD, and Francisco J Esteva, MD, PhD
Cancer Reports 2023
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis Slamon, et al
N Engl J Med 2020
bottom of page